PURE® SupraPhysiologic with AspiraDome™
What’s New?
The AspiraDome™ incorporates a patented technology that improves visualization, centralizes the buffy-coat, and enables more accurate, controlled aspiration. This innovation offers:
• Improved PRP purity and versatility with even less RBC’s contamination
• Consistent platelet yield with complete buffy-coat isolation and capture
• Expanded PRP composition to support evidence-based care
• Streamlined workflow with the elimination of the FLIP-VENT
The Future is now with AspiraDome™
Step into the future of regenerative biologics with the patented PURE® SupraPhysiologic Concentrating System featuring AspiraDome™ technology. AspiraDome™ is a guided buffycoat collection innovation that optimizes platelet and progenitor cell collection. This new innovation brings SupraPhysiologic processing to perfection allowing it to be the most advanced autologous concentrating system ever developed for point of care applications. It’s purpose-built to eliminate variability and maximize performance. This next-generation system redefines what’s possible in point-of-care biologic preparation.
Unmatched Platelet Recovery
Exceptional Platelet Yield
Say goodbye to guesswork and hello to precision you can count on. Achieve over 80% platelet yield in leukocyte-poor PRP and over 90% in both monocyte and neutrophil-rich PRP. This is performance without compromise, delivering unmatched consistency and reliability. Set a new standard in your practice with biologics engineered for predictable, high-yield results.
Red Blood Cell Reduction
Minimizing red blood cell contamination in PRP formulations enhances treatment by reducing the potential for inflammation and oxidative stress. In leukocyte-poor PRP, less than 1% RBC content creates a clean, regenerative environment ideal for healing soft tissue and joints, while in monocyte-rich PRP, keeping RBCs low helps preserve the therapeutic benefits of modulated inflammation. This level of purity ensures greater biologic precision, improved cellular viability, and more consistent clinical outcomes.
Its All About Monocytes
Monocyte Rich PRP
Monocyte-rich PRP, with capture rates up to 90%, is designed to enhance regenerative outcomes by concentrating monocytes while precisely regulating neutrophil content. Once delivered, these monocytes promote M2 macrophage polarization, shifting the tissue environment from inflammation toward repair, angiogenesis, and tissue regeneration. This polarization also delivers powerful immunomodulatory and antimicrobial effects, supporting both healing and defense. The result is a clinically advanced PRP formulation that supports functional recovery, and overall treatment efficacy.
No More Flip Vents
Designed in response to real-world clinician feedback, we have eliminated the flip vent hassle to simplify the user experience. By removing this cumbersome step, clinicians can now perform each stage of PRP processing with greater ease and efficiency. This enhancement shortens preparation time, reduces the risk of user error, and allows for a more seamless integration into clinical workflows. The result is a more intuitive system that enhances confidence and consistency with every use.
